インプラントポート市場調査レポート：材料タイプ別（シリコン、ポリウレタン、チタン）、用途別（化学療法、抗生物質療法、総合非経口栄養、輸血）、挿入方法別（外科的挿入、経皮的挿入）、地域別（北米、欧州、南米、アジア太平洋、中東・アフリカ）：2035年までの予測
Implantable Port Market Research Report By Material Type (Silicone, Polyurethane, Titanium), By Application (Chemotherapy, Antibiotic Therapy, Total Parenteral Nutrition, Blood Transfusion), By Insertion Method (Surgical Insertion, Percutaneous Insertion) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) Forecast to 2035
埋め込み型ポートの市場調査レポート：材料タイプ別（シリコン、ポリウレタン、チタン）、用途別（化学療法、抗生物質療法、総合非経口栄養、輸血）、挿入方法別（外科的挿入、経皮的挿入）、地域別（北米、欧州... もっと見る
|
|
サマリー 埋め込み型ポートの市場調査レポート：材料タイプ別（シリコン、ポリウレタン、チタン）、用途別（化学療法、抗生物質療法、総合非経口栄養、輸血）、挿入方法別（外科的挿入、経皮的挿入）、地域別（北米、欧州、南米、アジア太平洋、中東、アフリカ）2035年までの予測
市場の概要
MRFRの調査によると、植込み型ポート市場規模は2024年に32億9,028万米ドルと予測された。植込み型ポート市場産業は、予測期間（2025年〜2035年）にCAGR（成長率）6.21％で発展すると予測されています。
慢性疾患の蔓延が植え込み型ポート市場を牽引し、長期的な静脈アクセスオプションのニーズが高まっている。医療従事者が患者の快適性と治療効果の向上に注力するにつれ、埋め込み型ポートの人気が高まっている。外来患者や在宅医療の環境は拡大しており、これらの施設では一貫性のある効率的な投薬方法が必要とされるため、これも需要の原動力となっている。医療技術の向上も、より安全で耐久性のあるインプラントを保証し、市場拡大をさらに後押ししている。市場の可能性には、生体適合性を促進し感染リスクを低減する材料の創出が含まれ、その結果、より独創的なインプラントポート設計への道が開かれる。患者中心の医療を重視する傾向が強まれば、患者管理を強化するために遠隔モニタリングシステムなどのデジタルヘルス技術を含める可能性が広がる。植え込み型ポートの利点に関する医療従事者の知識の向上は、特にこのような技術がまだ受け入れられていない未開発地域での市場浸透を後押しする。最近の傾向として、低侵襲治療への移行が見られ、植え込み型ポートは患者と医師の双方にとってより魅力的なものとなるだろう。メーカーと医師が協力して、これらの機器の設計と使用方法の向上を目指すことは、より一般的になってきている。
市場セグメントに関する洞察
世界の埋め込み型ポート市場は、素材の種類によってシリコン、ポリウレタン、チタンに分けられる。
世界の埋め込み型ポート市場は、用途によって化学療法、抗生物質療法、完全非経口栄養、輸血に分けられている。
世界の埋め込み型ポート市場は、挿入技術によって外科的挿入と経皮的挿入に分けられる。予測期間中に最も急速に拡大している分野は、外科的挿入分野で、2024年の市場規模は最大であった。
地域知識
世界の埋め込み型ポート市場は、地域によって北米、欧州、アジア太平洋、南米、中東・アフリカに分けられる。2024年には北米が最大の市場シェアを占め、2035年には24億1,661万ドルに達すると予測されている。一方、アジア太平洋地域は、予測期間を通じて最も速いCAGR 8.32％で拡大すると予測されている。
予測期間を通じて5.20%のCAGRが予測される北米の埋め込み型ポート市場は、2024年に13億8,275万米ドルを稼いだ。北米も米国とカナダに分けられる。
予測期間中のCAGRは6.41%と予測され、欧州の埋め込み型ポート市場は2024年に9億7,235万米ドルとなった。欧州はその他欧州、ロシア、スペイン、イタリア、フランス、英国、ドイツに分けられる。
主要企業
植込み型ポート市場の主要企業には、Easton Medical、Baxter International、Zyga Technology、Terumo、Apex Medical Technologies、Medtronic、Boston Scientific、Cook Medical、AngioDynamics、Kirwan Surgical Products、Smiths Medical、Nitinol Devices Corporation、C R Bard、Stryker、Halyard Healthなどがある。
ページTOPに戻る
目次 目次
1.
1.
1.
1.
1.
1.
1.
2.
2.
2.
2.
3.
3.
3.
3.
3.
3.
3.
3.
3.
3.
3.
3.
3.
3.
3.
3.
3.
3.
4.
4.
4.
4.
4.
4.
4.
4.
4.
4.
4.
5.
5.
5.
5.
5.
5.
5.
5.
5.
5.
5.
5.
6.
6.
6.
6.
7.
7.
7.
7.
7.
8.
8.
8.
8.
9.
9.
9.
10.
10.
10.
10.
10.
10.
10.3.2 フランス .........................................................................................................................................................................................................
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.5.1 ブラジル ...............................................................................................................................................................................................................
10.
10.
10.
10.
10.
10.
10.
11.
11.
11.
11.
11.
11.
11.
11.
12.1 アンジオダイナミクス株式会社
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.150
12.151
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.9 PAKUMEDEDICAL PRODUCTS GmbH .................................................................................................................................................................................................
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
ページTOPに戻る
Summary Implantable Port Market Research Report By Material Type (Silicone, Polyurethane, Titanium), By Application (Chemotherapy, Antibiotic Therapy, Total Parenteral Nutrition, Blood Transfusion), By Insertion Method (Surgical Insertion, Percutaneous Insertion) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) Forecast to 2035
Overview of the Market
According to MRFR research, the Implantable Port Market Size was projected at 2024 USD 3,290.28 Million. The Implantable Port Market Industry is projected to develop at a CAGR (growth rate) of 6.21% over the forecast period (2025 - 2035).
Rising prevalence of chronic diseases drive the Implantable Port Market, which in turn increases the need for long-term intravenous access options. Implantable ports are becoming more popular as healthcare practitioners concentrate on improving patient comfort and treatment efficacy. Outpatient and home healthcare environments are expanding, which also drives demand as these facilities need consistent, efficient ways to deliver medication. Improvements in medical technology also guarantee safer, more durable implants, hence driving market expansion even more. Market possibilities include the creation of materials encouraging biocompatibility and reducing infection risk, therefore opening the path for more creative implantable port designs. Increasing patient-centric care focus opens up possibilities for including digital health technologies—such as remote monitoring systems—to enhance patient management. Increasing knowledge among healthcare professionals about the advantages of implantable ports can help to boost market penetration as well, particularly in underdeveloped areas where such technology is still being accepted. Recent trends show a move toward minimally invasive treatments, which would make implantable ports more appealing to both patients and doctors. Manufacturers and doctors working together are more common as they seek to enhance the design and use of these gadgets.
Insights on Market Segments
The worldwide implanted port market has been divided into silicone, polyurethane, and titanium depending on material kind.
The global implantable port market has been divided into chemotherapy, antibiotic therapy, complete parenteral nutrition, and blood transfusion depending on application.
The worldwide implantable port market has been divided into surgical insertion and percutaneous insertion depending on insertion technique. The fastest expanding sector during the forecast period, the surgical insertion segment had the largest market in 2024.
Regional Knowledge
The worldwide implantable port market has been divided into North America, Europe, Asia-Pacific, South America, and the Middle East & Africa depending on the area. In 2024, North America had the biggest market share and is projected to reach USD 2,416.61 million by 2035. On the other hand, Asia-Pacific is expected to expand at the fastest CAGR of 8.32% throughout the forecast period.
With a predicted CAGR of 5.20% throughout the forecast period, the North America implantable port market made USD 1,382.75 million in 2024. North America is also divided into the US and Canada.
With a predicted CAGR of 6.41% throughout the projection period, the Europe implantable port market was USD 972.35 million in 2024. Europe is divided more into Rest of Europe, Russia, Spain, Italy, France, UK, and Germany.
Key Players
Major Companies in the Implantable Port Market Include Easton Medical, Baxter International, Zyga Technology, Terumo, Apex Medical Technologies, Medtronic, Boston Scientific, Cook Medical, AngioDynamics, Kirwan Surgical Products, Smiths Medical, Nitinol Devices Corporation, C R Bard, Stryker, and Halyard Health.
ページTOPに戻る
Table of Contents TABLE OF CONTENTS
1 EXECUTIVE SUMMARY ............................................................................................................... 19
1.1 OVERVIEW .................................................................................................................................................................... 19
1.2 MARKET ATTRACTIVENESS ANALYSIS ........................................................................................................... 20
1.3 GLOBAL IMPLANTABLE PORT MARKET, BY MATERIAL TYPE ................................................................ 21
1.4 GLOBAL IMPLANTABLE PORT MARKET, BY APPLICATION ...................................................................... 22
1.5 GLOBAL IMPLANTABLE PORT MARKET, BY END USER .............................................................................. 23
1.6 GLOBAL IMPLANTABLE PORT MARKET, BY INSERTION METHOD ........................................................ 24
1.7 GLOBAL IMPLANTABLE PORT MARKET, BY REGION ................................................................................... 25
2 MARKET INTRODUCTION ............................................................................................................ 27
2.1 DEFINITION .................................................................................................................................................................. 27
2.2 SCOPE OF THE STUDY .............................................................................................................................................. 27
2.3 RESEARCH OBJECTIVE ............................................................................................................................................ 27
2.4 MARKET STRUCTURE .............................................................................................................................................. 27
3 RESEARCH METHODOLOGY ...................................................................................................... 28
3.1 OVERVIEW .................................................................................................................................................................... 28
3.2 DATA FLOW .................................................................................................................................................................. 30
3.2.1 Data Mining Process ....................................................................................................................................... 30
3.3 PURCHASED DATABASE: ......................................................................................................................................... 31
3.4 SECONDARY SOURCES: ............................................................................................................................................ 32
3.4.1 Secondary Research Data Flow: ....................................................................................................................... 33
3.5 PRIMARY RESEARCH: ............................................................................................................................................... 34
3.5.1 Primary Research Data Flow: .......................................................................................................................... 35
3.5.2 Primary Research: Number of Interviews conducted ........................................................................................ 36
3.5.3 Primary Research: Regional Coverage ............................................................................................................. 36
3.6 APPROACHES FOR MARKET SIZE ESTIMATION: ........................................................................................... 37
3.6.1 Revenue Analysis Approach ............................................................................................................................ 37
3.7 DATA FORECASTING................................................................................................................................................. 38
3.7.1 Data forecasting Type ..................................................................................................................................... 38
3.8 DATA MODELING ........................................................................................................................................................ 39
3.8.1 Microeconomic Factor Analysis: ...................................................................................................................... 39
3.8.2 Data modeling: ............................................................................................................................................... 40
3.9 TEAMS AND ANALYST CONTRIBUTION ........................................................................................................... 42
4 MARKET DYNAMICS .................................................................................................................... 44
4.1 INTRODUCTION ........................................................................................................................................................... 44
4.2 DRIVERS ......................................................................................................................................................................... 44
4.2.1 Increasing Incidences of Chronic Diseases across the globe............................................................................. 44
4.2.2 Technological Advancements .......................................................................................................................... 45
4.2.3 Better Healthcare Access ................................................................................................................................ 46
4.3 RESTRAINTS ................................................................................................................................................................ 47
4.3.1 High Cost of Implantation ............................................................................................................................... 47
4.3.2 Surgical Risks ................................................................................................................................................. 47
4.4 OPPORTUNITY ............................................................................................................................................................. 48
4.4.1 Expansion in Emerging Markets ....................................................................................................................... 48
4.4.2 Growing Aging Population ............................................................................................................................... 48
5 MARKET FACTOR ANALYSIS ...................................................................................................... 49
5.1 VALUE CHAIN ANALYSIS ....................................................................................................................................... 49
5.1.1 R&D ............................................................................................................................................................... 49
5.1.2 Manufacturing ................................................................................................................................................ 49
5.1.3 Marketing and Distribution & Channel .............................................................................................................. 49
5.1.4 Post-market Surveillance ................................................................................................................................ 50
5.2 PORTER'S FIVE FORCES MODEL ........................................................................................................................... 50
5.2.1 Threat of New Entrants ................................................................................................................................... 51
5.2.2 Bargaining Power of Suppliers ......................................................................................................................... 51
5.2.3 Threat of Substitutes ...................................................................................................................................... 52
5.2.4 Bargaining Power of Buyers ............................................................................................................................ 52
5.2.5 Intensity of Rivalry .......................................................................................................................................... 52
5.3 IMPACT OF COVID-19 ON THE GLOBAL IMPLANTABLE PORT MARKET ............................................... 53
6 GLOBAL IMPLANTABLE PORT MARKET, BY MATERIAL TYPE ................................................. 55
6.1 OVERVIEW .................................................................................................................................................................... 55
6.2 SILICONE ........................................................................................................................................................................ 57
6.3 POLYURETHANE ........................................................................................................................................................ 58
6.4 TITANIUM ..................................................................................................................................................................... 58
7 GLOBAL IMPLANTABLE PORT MARKET, BY APPLICATION ...................................................... 59
7.1 OVERVIEW .................................................................................................................................................................... 59
7.2 CHEMOTHERAPY ....................................................................................................................................................... 61
7.3 ANTIBIOTIC THERAPY ............................................................................................................................................. 62
7.4 TOTAL PARENTERAL NUTRITION ...................................................................................................................... 62
7.5 BLOOD TRANSFUSION .............................................................................................................................................. 63
8 GLOBAL IMPLANTABLE PORT MARKET, BY END USER ........................................................... 64
8.1 OVERVIEW .................................................................................................................................................................... 64
8.2 HOSPITALS ................................................................................................................................................................... 66
8.3 AMBULATORY SURGICAL CENTERS ................................................................................................................... 67
8.4 SPECIALIZED CLINICS ............................................................................................................................................... 67
9 GLOBAL IMPLANTABLE PORT MARKET, BY INSERTION METHOD ......................................... 68
9.1 OVERVIEW .................................................................................................................................................................... 68
9.2 SURGICAL INSERTION .............................................................................................................................................. 70
9.3 PERCUTANEOUS INSERTION ................................................................................................................................. 71
10 GLOBAL IMPLANTABLE PORT MARKET, BY REGION ............................................................... 72
10.1 OVERVIEW .................................................................................................................................................................... 72
10.2 NORTH AMERICA ....................................................................................................................................................... 74
10.2.1 US.................................................................................................................................................................. 77
10.2.2 CANADA ........................................................................................................................................................ 78
10.3 EUROPE .......................................................................................................................................................................... 80
10.3.1 GERMANY ...................................................................................................................................................... 83
10.3.2 FRANCE ......................................................................................................................................................... 84
10.3.3 UK ................................................................................................................................................................. 86
10.3.4 ITALY ............................................................................................................................................................. 88
10.3.5 SPAIN ............................................................................................................................................................ 90
10.3.6 RUSSIA .......................................................................................................................................................... 92
10.3.7 REST OF EUROPE ............................................................................................................................................ 94
10.4 ASIA-PACIFIC ............................................................................................................................................................... 96
10.4.1 CHINA ............................................................................................................................................................ 99
10.4.2 INDIA ............................................................................................................................................................. 100
10.4.3 JAPAN ........................................................................................................................................................... 102
10.4.4 SOUTH KOREA ................................................................................................................................................ 103
10.4.5 MALAYSIA ..................................................................................................................................................... 104
10.4.6 THAILAND ...................................................................................................................................................... 106
10.4.7 INDONESIA ..................................................................................................................................................... 107
10.4.8 REST OF ASIA-PACIFIC ................................................................................................................................... 108
10.5 SOUTH AMERICA ....................................................................................................................................................... 110
10.5.1 BRAZIL ........................................................................................................................................................... 113
10.5.2 MEXICO ......................................................................................................................................................... 114
10.5.3 ARGENTINA ................................................................................................................................................... 116
10.5.4 REST OF SOUTH AMERICA .............................................................................................................................. 117
10.6 MIDDLE EAST AND AFRICA .................................................................................................................................... 119
10.6.1 GCC COUNTRIES............................................................................................................................................. 122
10.6.2 SOUTH AFRICA ............................................................................................................................................... 123
10.6.3 REST OF MIDDLE EAST AND AFRICA ................................................................................................................ 125
11 COMPETITIVE LANDSCAPE ........................................................................................................ 128
11.1 INTRODUCTION ........................................................................................................................................................... 128
11.2 COMPANY MARKET SHARE ANALYSIS, 2024 (VALUE) ............................................................................... 128
11.3 COMPETITOR DASHBOARD..................................................................................................................................... 129
11.4 PUBLIC PLAYERS STOCK SUMMARY ................................................................................................................. 130
11.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL .............................................................................. 130
11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES ............................................................................................ 130
11.6.1 DONATION ..................................................................................................................................................... 130
11.6.2 AGREEMENT .................................................................................................................................................. 131
12 COMPANY PROFILES .................................................................................................................. 132
12.1 ANGIODYNAMICS, INC. ............................................................................................................................................. 132
12.1.1 COMPANY OVERVIEW ..................................................................................................................................... 132
12.1.2 FINANCIAL OVERVIEW .................................................................................................................................... 133
12.1.3 PRODUCTS/SOLUTIONS/SERVICES OFFERED ................................................................................................... 134
12.1.4 KEY DEVELOPMENTS ...................................................................................................................................... 135
12.1.5 SWOT ANALYSIS ............................................................................................................................................ 136
12.1.6 KEY STRATEGIES ............................................................................................................................................ 136
12.2 B. BRAUN MELSUNGEN AG .................................................................................................................................... 137
12.2.1 COMPANY OVERVIEW ..................................................................................................................................... 137
12.2.2 FINANCIAL OVERVIEW .................................................................................................................................... 138
12.2.3 PRODUCTS/SOLUTIONS/SERVICES OFFERED ................................................................................................... 138
12.2.4 KEY DEVELOPMENTS ...................................................................................................................................... 139
12.2.5 SWOT ANALYSIS ............................................................................................................................................ 139
12.2.6 KEY STRATEGIES ............................................................................................................................................ 139
12.3 BECTON, DICKINSON AND COMPANY (BD) ....................................................................................................... 140
12.3.1 COMPANY OVERVIEW ..................................................................................................................................... 140
12.3.2 FINANCIAL OVERVIEW .................................................................................................................................... 141
12.3.3 PRODUCTS/SOLUTIONS/SERVICES OFFERED ................................................................................................... 141
12.3.4 KEY DEVELOPMENTS ...................................................................................................................................... 142
12.3.5 SWOT ANALYSIS ............................................................................................................................................ 142
12.3.6 KEY STRATEGIES ............................................................................................................................................ 143
12.4 COOK MEDICAL LLC ................................................................................................................................................... 144
12.4.1 COMPANY OVERVIEW ..................................................................................................................................... 144
12.4.2 FINANCIAL OVERVIEW .................................................................................................................................... 144
12.4.3 PRODUCTS/SOLUTIONS/SERVICES OFFERED ................................................................................................... 145
12.4.4 KEY DEVELOPMENTS ...................................................................................................................................... 145
12.4.5 SWOT ANALYSIS ............................................................................................................................................ 145
12.4.6 KEY STRATEGIES ............................................................................................................................................ 146
12.5 DISTRICLASS MEDICAL SA ..................................................................................................................................... 147
12.5.1 COMPANY OVERVIEW ..................................................................................................................................... 147
12.5.2 FINANCIAL OVERVIEW .................................................................................................................................... 147
12.5.3 PRODUCTS/SOLUTIONS/SERVICES OFFERED ................................................................................................... 147
12.5.4 KEY DEVELOPMENTS ...................................................................................................................................... 147
12.5.5 SWOT ANALYSIS ............................................................................................................................................ 148
12.5.6 KEY STRATEGIES ............................................................................................................................................ 148
12.6 VYGON ............................................................................................................................................................................ 149
12.6.1 COMPANY OVERVIEW ..................................................................................................................................... 149
12.6.2 FINANCIAL OVERVIEW .................................................................................................................................... 150
12.6.3 PRODUCTS/SOLUTIONS/SERVICES OFFERED ................................................................................................... 150
12.6.4 KEY DEVELOPMENTS ...................................................................................................................................... 151
12.6.5 SWOT ANALYSIS ............................................................................................................................................ 151
12.6.6 KEY STRATEGIES ............................................................................................................................................ 152
12.7 SILMAG AG.................................................................................................................................................................... 153
12.7.1 COMPANY OVERVIEW ..................................................................................................................................... 153
12.7.2 FINANCIAL OVERVIEW .................................................................................................................................... 153
12.7.3 PRODUCTS/SOLUTIONS/SERVICES OFFERED ................................................................................................... 153
12.7.4 KEY DEVELOPMENTS ...................................................................................................................................... 153
12.7.5 SWOT ANALYSIS ............................................................................................................................................ 154
12.7.6 KEY STRATEGIES ............................................................................................................................................ 154
12.8 POLY MEDICURE LTD ................................................................................................................................................ 155
12.8.1 COMPANY OVERVIEW ..................................................................................................................................... 155
12.8.2 FINANCIAL OVERVIEW .................................................................................................................................... 156
12.8.3 PRODUCTS/SOLUTIONS/SERVICES OFFERED ................................................................................................... 156
12.8.4 KEY DEVELOPMENTS ...................................................................................................................................... 158
12.8.5 SWOT ANALYSIS ............................................................................................................................................ 158
12.8.6 KEY STRATEGIES ............................................................................................................................................ 159
12.9 PAKUMEDMEDICAL PRODUCTS GMBH ............................................................................................................. 160
12.9.1 COMPANY OVERVIEW ..................................................................................................................................... 160
12.9.2 FINANCIAL OVERVIEW .................................................................................................................................... 160
12.9.3 PRODUCTS/SOLUTIONS/SERVICES OFFERED ................................................................................................... 161
12.9.4 KEY DEVELOPMENTS ...................................................................................................................................... 161
12.9.5 SWOT ANALYSIS ............................................................................................................................................ 162
12.9.6 KEY STRATEGIES ............................................................................................................................................ 162
12.10 SOPHYSA ....................................................................................................................................................................... 163
12.10.1 COMPANY OVERVIEW ..................................................................................................................................... 163
12.10.2 FINANCIAL OVERVIEW .................................................................................................................................... 163
12.10.3 PRODUCTS/SOLUTIONS/SERVICES OFFERED ................................................................................................... 164
12.10.4 KEY DEVELOPMENTS ...................................................................................................................................... 164
12.10.5 SWOT ANALYSIS ............................................................................................................................................ 164
12.10.6 KEY STRATEGIES ............................................................................................................................................ 165
13 DATA CITATIONS ......................................................................................................................... 166
ページTOPに戻る
- Global 3D-Printed Orthopedic Implants Market Research Report 2026
- Global Ophthalmic Equipment Market Size Study & Forecast, by Product (Diagnostic and Monitoring Devices, Optical Coherence Tomography Scanners), by End User (Consumers, Hospitals), by Application and Regional Forecasts 2025-2035
- Global Neurovascular Devices Market Size Study & Forecast, by Type (Neurothrombectomy Devices, Embolization Devices, Angioplasty Devices), by Application (Ischemic Stroke, Aneurysm, Stenosis, Arteriovenous Malformations), End User (Hospitals and Specialty Clinics, Ambulatory Care Centers and Other End Users) and Regional Forecasts 2025-2035
- Global Surgical Gowns and Drapes Market Size Study, by Type (Surgical Drapes, Surgical Gowns), by Usage Pattern (Disposable, Reusable), by End-User (Hospitals, Ambulatory Surgical Centers, Others), by Risk Type (Moderate (AAMI Level 3), Minimal (AAMI Level 1)) and Regional Forecasts 2025-2035
- Global Preclinical Imaging Market Size Study & Forecast, by Product (Systems and Services), by Reagents (Optical, Nuclear, MRI, Ultrasound, CT), Application and Regional Forecasts 2025-2035
- Global Pediatric Vascular Access Market Size Study & Forecast, by Type (Catheters (CVC, PIVC, PICC), Ports, IV Sets, Infusion Pumps), by Application (Drug Administration, Blood Transfusion, Diagnostics & Testing) and Regional Forecasts 2025-2035
- Global Medical Stick-to-Skin Adhesives Market Size Study & Forecast, by Type (Electrode Adhesives, Transdermal Drug Delivery, Specialized Adhesives), Product (Acrylic, Silicon, Rubber, Hydrogel), By Application (Surgery, Wound Dressing, Ostomy Seals), By Formulation Type (Pressure sensitive Adhesives, Water soluble Adhesives, Solvent based Adhesives, Hotmelt Adhesives), By End user (Hospitals, Clinics, Home Healthcare, Research Laboratories), and Regional Forecasts 2025-2035
- Global IVD Labware Market Size Study, by Product (Plastic [Tubes, Plates, Pipettes, Cuvettes], Glass [Beakers, Vials, Petri Dish, Slides]), by Type (Reusable, Single-use), By Application (Clinical Chemistry, MDx, Immunoassay, By End user (clinical laboratories, hospitals, academic institutes, Others), and Regional Forecasts 2025-2035
- 呼気分析装置市場：技術別（燃料電池、酸化物半導体センサー、その他の技術）、用途別（アルコール検知、薬物乱用検知、医療用途）、エンドユーザー別（法執行機関、企業）－2031年までの世界市場予測
- サービス別（創薬、原薬開発、薬事規制対応、コンサルティング、包装・ラベル貼付）、製品別（原薬、充填・仕上げ、医療機器）、動物種別（伴侶動物、家畜）の獣医用受託製造・研究市場 ― 2031年までの世界予測
Market Research Future社の 医療機器分野 での最新刊レポート
よくあるご質問
Market Research Future社はどのような調査会社ですか?
マーケットリサーチフューチャー（Market Research Future）は世界市場を幅広く調査し、主要分野、地域、国レベルの調査レポートを出版しています。
下記分野については、分野毎に専... もっと見る
調査レポートの納品までの日数はどの程度ですか?
在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。
注文の手続きはどのようになっていますか?
1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。
お支払方法の方法はどのようになっていますか?
納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。
データリソース社はどのような会社ですか?
当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。
|
|
